Laboratorios Farmaceuticos Rovi
ROVI.MC
#3423
Rank
HK$26.36 B
Marketcap
HK$515.50
Share price
-1.87%
Change (1 day)
7.94%
Change (1 year)

Earnings for Laboratorios Farmaceuticos Rovi (ROVI.MC)

Earnings in 2024 (TTM): HK$1.61 Billion

According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current earnings are HK$0.84 Billion. In 2023 the company made an earning of HK$1.86 Billion a decrease over its 2022 earnings that were of HK$2.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Laboratorios Farmaceuticos Rovi from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$1.61 B-13.31%
2023 HK$1.86 B-12.68%
2022 HK$2.13 B29.26%
2021 HK$1.65 B149.39%
2020 HK$0.66 B79.65%
2019 HK$0.36 B128.8%
2018 HK$0.16 B0.15%
2017 HK$0.16 B-35.28%
2016 HK$0.24 B27.59%
2015 HK$0.19 B-32.06%
2014 HK$0.28 B8.39%
2013 HK$0.26 B-4.32%
2012 HK$0.27 B2.78%
2011 HK$0.26 B-2.15%
2010 HK$0.27 B